Nanomedicine Revolution the Role of Sugar-Based Biopolymers in Cancer Imaging and Therapeutic Applications
*Corresponding Author: Claying Long, Department of Functional and Morphological Science, Faculty of Medicine and Pharmacy, Dunarea de Jos University, Romania, Email: Longcying@gmail.comReceived Date: Oct 02, 2024 / Published Date: Oct 31, 2024
Citation: Claying L (2024) Nanomedicine Revolution the Role of Sugar-BasedBiopolymers in Cancer Imaging and Therapeutic Applications. Biopolymers Res8: 231.
Copyright: © 2024 Claying L. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
Sugar-based biopolymers, derived from natural carbohydrates, have gained significant attention in the field of nanomedicine due to their biocompatibility, biodegradability, and versatility. This article reviews the innovative applications of sugar-based biopolymers in cancer imaging and therapy, highlighting their potential to enhance diagnostic accuracy and therapeutic efficacy. The review covers various types of sugar-based biopolymers, including dextran, chitosan, and hyaluronic acid, focusing on their roles as drug carriers, imaging agents, and therapeutic platforms. We also discuss recent advancements in nanoparticle formulation, targeting strategies, and multimodal imaging techniques. The findings indicate that sugar-based biopolymers hold great promise for revolutionizing cancer management by enabling precise imaging and targeted drug delivery.